Amarin is a clinical-stage biopharmaceutical company focused on the enhanced treatment of cardiovascular disease. Amarin’s cardiovascular programs capitalize on the company’s expertise in lipid science and the known therapeutic benefits of essential fatty acids in treating cardiovascular disease. The company’s lead candidate is AMR101. For more information visit the company’s Web site at www.amarincorp.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: